Skip to main content
Clinical Trials/NCT01729650
NCT01729650
Completed
N/A

Effectiveness of a Physical Activity and Diet Program, Coordinated Between Primary Care and Mental Health, to Modify Cardiovascular Risk Factors in Patients With Schizophrenia or Bipolar Disorder (CapiCor)

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina1 site in 1 country332 target enrollmentJune 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Schizophrenic Disorders
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Enrollment
332
Locations
1
Primary Endpoint
waist circumference (cm)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim is to evaluate the effectiveness of an intervention based on a program of physical activity and diet coordinated between primary care teams (PCT) and Mental Health Centres (MHC) to modify the weekly physical activity (PA) amount, body mass index (BMI) and waist circumference in patients with severe mental disorder diagnoses. To assess changes in cardiovascular risk, quality of life and lifestyles, secondarily. Methods: A randomized clinical trial with a control group, of one year of follow-up, carried out in four MHC Barcelona and Santa Coloma, and PCT of reference. The investigators studied patients aged 18 - 65 years old, diagnosed with schizophrenia, schizoaffective or bipolar disorder, with antipsychotic medication and a low level of PA. 240 patients will be selected in each group (difference to be detected in the BMI:> 1.89 kg/m2; common SD: 6.2, 30% loss). Intervention: group educational PA program (basically walking) of 24 sessions over 12 weeks, and diet (8 sessions in the first 8 weeks) by nurses and specialists in PA. Key measurements: level of PA (IPAQ questionnaire), physical examinations: BMI, waist circumference, blood pressure, cardiovascular risk, quality of life (SF-36), smoking habits, dietary habits (PREDIMED questionnaire), analytical parameters: cholesterol , triglycerides, blood glucose. Evaluations will be masked and conducted at 0, 3, 6 and 12 months. Analysis of variance for repeated measures to adjust for differences attributable to the effect of the intervention for potential confounders: pharmacological treatment, care level of intervention and mental state.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
December 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age between 18 and 65 years old,
  • understand Catalan or Spanish
  • will be located for at least twelve months.
  • Psychiatric disorders with ICD-10 diagnosis codes: F20\*, F31\* and F25\*.
  • Taking an antipsychotic drug at, a least, three months
  • Low physical activity level

Exclusion Criteria

  • Active addiction to psychoactive drugs, except tobacco.
  • Pregnancy
  • Diseases that doesn't allow physical activity
  • Psychotic acute exacerbation in the last month

Outcomes

Primary Outcomes

waist circumference (cm)

Time Frame: : the outcome measure is studied at 3, 6 and 12 months

Change in weekly level of physical activity (IPAQ questionnaire),

Time Frame: : the outcome measure is studied at 3, 6 and 12 months

Body mass index (kg/m²)

Time Frame: : the outcome measure is studied at 3, 6 and 12 months

Secondary Outcomes

  • blood pressure (mm hg)(the outcome measure is studied at 3, 6 and 12 months)
  • cardiovascular risk with the Regicor coronary risk to 10 years(the outcome measure is studied at 3, 6 and 12 months)
  • Quality of life (SF-36 questionnaire)(the outcome measure is studied at 3, 6 and 12 months)
  • Dietary habits (PREDIMED questionnaire)(the outcome measure is studied at 3, 6 and 12 months)
  • Analytical parameters: cholesterol , triglycerides, blood glucose mg/100 ml.(the outcome measure is studied at 3, 6 and 12 months)
  • Smoking habits: smoker/ ex-smoker/no-smoker. Number of cigarettes per day.(the outcome measure is studied at 3, 6 and 12 months)

Study Sites (1)

Loading locations...

Similar Trials